Zobrazeno 1 - 10
of 73
pro vyhledávání: '"V. N. Dvirnyk"'
Autor:
E. I. Zakharko, V. N. Dvirnyk, Yu. A. Chabaeva, D. G. Drokova, E. B. Rybkina, K. A. Lavrishinets, A. V. Bulgakov, M. N. Panasenko, Z. T. Fidarova, I. A. Lukianova, O. A. Aleshina, S. M. Kulikov, T. V. Gaponova, V. V. Troitskaya, E. N. Parovichnikova
Publikováno v:
Онкогематология, Vol 19, Iss 2, Pp 34-45 (2024)
Background. Vascular endothelial growth factor A (VEGFA) is one of the most important factors for regulation of hematopoietic stem cells differentiation. It is involved in leukemogenesis and central nervous system (CNS) damage in acute leukemia. Acco
Externí odkaz:
https://doaj.org/article/55d39ee6b6134f1db6b448704192c604
Autor:
A. N. Vasileva, O. A. Aleshina, E. S. Kotova, B. V. Biderman, T. N. Obukhova, I. V. Galtseva, V. N. Dvirnyk, E. I. Zakharko, A. B. Sudarikov, E. N. Parovichnikova
Publikováno v:
Онкогематология, Vol 19, Iss 2, Pp 14-25 (2024)
Background. Current chemotherapy protocols for T-cell acute lymphoblastic leukemia (T-ALL) allow achieving a 5-year overall survival of 60–90 %, but relapsed and refractory forms remain incurable situations.Aim. To determine the significance of imm
Externí odkaz:
https://doaj.org/article/adedd1175d824e51baec49dd4a48c0c7
Autor:
B. D. Chaltsev, A. V. Torgashina, A. M. Lila, T. V. Markova, S. I. Kutsev, O. P. Ryzhkova, A. A. Orlova, A. V. Kokhno, T. I. Solovyova, V. N. Dvirnyk, A. M. Kovrigina, T. N. Obukhova, E. N. Parovichnikova, E. L. Nasonov
Publikováno v:
Современная ревматология, Vol 17, Iss 6, Pp 92-101 (2023)
This article presents the first case of VEXAS syndrome identified in the Russian Federation as well as characteristics of currently known clinical manifestations and treatment approaches. The clinical observation described is an impressive example of
Externí odkaz:
https://doaj.org/article/384c3eebf67e4465a4859c058c2a6f75
Autor:
K. A. Pekhova, Yu. V. Sidorova, N. A. Severina, O. A. Glinshchikova, I. S. Fevraleva, B. V. Biderman, Yu. A. Chabaeva, S. M. Kulikov, I. A. Luk’yanova, A. I. Kashlakova, T. N. Obukhova, V. N. Dvirnyk, A. B. Sudarikov
Publikováno v:
Онкогематология, Vol 18, Iss 3, Pp 102-114 (2023)
Background. Tumor cell proliferation in acute myeloid leukemia (AML) may manifest with high leukocyte counts. In our work, we evaluate the association of high leukocyte counts with individual mutations, as well as their total contribution to the deve
Externí odkaz:
https://doaj.org/article/f6c43010c61f498ebdddc2d3c851444f
Autor:
E. S. Kotova, O. A. Gavrilina, I. A. Yakutik, A. B. Sudarikov, Yu. A. Chabaeva, S. M. Kulikov, S. G. Beksaev, V. V. Troitskaya, G. A. Isinova, A. N. Sokolov, Z. T. Fidarova, I. A. Lukyanova, A. V. Abramova, V. N. Dvirnyk, I. V. Galtseva, T. N. Obukhova, E. N. Parovichnikova
Publikováno v:
Онкогематология, Vol 17, Iss 3, Pp 98-107 (2022)
Background. 6-mercaptopurine (6-MP) is a drug that is included in the treatment protocols for children and adults with acute lymphoblastic leukemias/lymphomas (ALL/LBL). It is known that individual differences in 6-MP tolerance can be explained by th
Externí odkaz:
https://doaj.org/article/258f0daa502345c7a75d1d9529faa844
Autor:
I. G. Rekhtina, E. V. Kazarina, E. S. Stolyarevich, A. M. Kovrigina, V. N. Dvirnyk, S. M. Kulikov, L. P. Mendeleeva
Publikováno v:
Терапевтический архив, Vol 92, Iss 7, Pp 63-69 (2020)
Aim.Reveal morphological and immunohistochemical predictors of reversibility of dialysis-dependent acute kidney injury (AKI) in patients with myeloma cast nephropathy (MCN) based on the study of kidney biopsy. Materials and methods.Renal pathologi
Externí odkaz:
https://doaj.org/article/334f035c8652478d9f44c3b8758a6230
Autor:
E. A. Mikhaylova, Z. T. Fidarova, A. V. Abramova, A. V. Luchkin, V. V. Troitskaya, V. N. Dvirnyk, I. V. Galtseva, G. A. Kliasova, A. M. Kovrigina, S. M. Kulikov, Yu. А. Chabaeva, E. N. Parovichnikova, V. G. Savchenko, T. N. Obukhova
Publikováno v:
Терапевтический архив, Vol 92, Iss 7, Pp 4-9 (2020)
Treatment programs for patients with acquired aplastic anemia include two main therapeutic options: allogeneic bone marrow transplantation and combined immunosuppressive therapy (IST). However, combined IST remains the method of choice for most adult
Externí odkaz:
https://doaj.org/article/574dc4370279402b82bb06755b177aa5
Autor:
M. V. Firsova, L. P. Mendeleeva, M. V. Solovev, I. G. Rekhtina, O. S. Pokrovskaya, E. S. Urnova, N. P. Soboleva, V. N. Dvirnyk, G. A. Klyasova, L. A. Kuzmina, V. G. Savchenko
Publikováno v:
Терапевтический архив, Vol 92, Iss 7, Pp 70-76 (2020)
Aim.To assess the safety and efficacy of autologous haematopoietic stem cell transplantation (auto-HSCT) in multiple myeloma (MM) patients with dialysis-dependent renal failure. Materials and methods.During a period from May 2010 to December 2016
Externí odkaz:
https://doaj.org/article/a01f94a3ddbe462b9ab261e3486d0445
Autor:
M. A. Kislitsyna, T. N. Obukhova, A. V. Kokhno, L. A. Grebenyuk, A. V. Luchkin, L. A. Kuzmina, V. N. Dvirnyk, A. M. Kovrigina, I. V. Galtseva, B. V. Biderman, V. V. Troitskaya, E. N. Parovichnikova
Publikováno v:
Онкогематология, Vol 14, Iss 3, Pp 69-76 (2019)
In chronic lymphocytic leukemia, the risk of second tumors including hematological malignancies, with which the use of purine nucleosides and alkylating agents in treatment of chronic lymphocytic leukemia is most often associated, is significantly in
Externí odkaz:
https://doaj.org/article/2c0272a5f1b14294822c10d7f61d9113
Autor:
O. Yu. Davydova, I. V. Galtseva, E. N. Parovichnikova, A. V. Kokhno, N. M. Kapranov, V. V. Troitskaya, E. A. Mikhailova, Z. T. Fidarova, T. N. Moiseeva, L. A. Kuzmina, E. A. Lukina, T. N. Obukhova, L. A. Grebenyuk, A. M. Kovrigina, V. N. Dvirnyk, V. G. Savchenko
Publikováno v:
Онкогематология, Vol 13, Iss 4, Pp 75-88 (2019)
Background . Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal diseases of the hematopoiesis system characterized by dismyelopoiesis and cytopenia, the presence of cytogenetic aberrations and a high risk of transformation into acute
Externí odkaz:
https://doaj.org/article/592c04ba19584ab391e530dd088ab289